ストックスクリーナーアプリを入手
5.73
4.66%
-0.28
前日終値:
$6.01
開ける：
$6
24時間の取引高:
1.33M
Relative Volume:
0.16
時価総額：
$447.26M
収益：
-
当期純損益:
$-209.96M
株価収益率:
-1.8133
EPS:
-3.16
ネットキャッシュフロー:
$-176.27M
1週間 パフォーマンス:
-9.48%
1か月 パフォーマンス:
+9.14%
6か月 パフォーマンス:
-52.68%
1年 パフォーマンス:
-44.80%
1日の値動き範囲:
$5.70
$6.0015
1週間の範囲:
$5.70
$6.3272
52週間の値動き範囲:
$2.68
$17.00
Replimune Group Inc Stock (REPL) Company Profile
REPL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
REPL
Replimune Group Inc
|
5.73 | 467.55M | 0 | -209.96M | -176.27M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Replimune Group Inc Stock (REPL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-07-23 | ダウングレード | BMO Capital Markets | Outperform → Underperform |
| 2025-07-23 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-07-23 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-07-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-07-22 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-07-22 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-22 | ダウングレード | Wedbush | Outperform → Neutral |
| 2025-06-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2023-04-17 | 再開されました | Piper Sandler | Overweight |
| 2021-11-19 | 開始されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2020-11-17 | 開始されました | BTIG Research | Buy |
| 2020-11-02 | 開始されました | Jefferies | Buy |
| 2020-10-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-07-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-05-05 | 開始されました | Barclays | Overweight |
| 2019-09-04 | 開始されました | ROTH Capital | Buy |
| 2019-07-23 | 開始されました | Chardan Capital Markets | Buy |
| 2019-07-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-07-08 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-25 | 開始されました | Wedbush | Outperform |
| 2019-01-23 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-08-14 | 開始されました | JP Morgan | Overweight |
| 2018-08-14 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Replimune Group Inc (REPL) 最新ニュース
REPL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, - GlobeNewswire
Investor Lawsuit Targets Replimune (REPL) After FDA Deems RP1 Trial InadequateHagens Berman - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - GlobeNewswire
Replimune Group, Inc. Class Action: Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025REPL - Morningstar
Replimune Group, Inc. (NASDAQ:REPL) Receives $6.50 Average Target Price from Brokerages - MarketBeat
What institutional flow reveals about Replimune Group Inc.July 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
REPL 2-WEEK DEADLINE ALERT: Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug ApprovalHagens Berman - PR Newswire
REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
REPL LAWSUIT ALERT: The Gross Law Firm Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Barchart.com
REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Exome Asset Management LLC Purchases 240,108 Shares of Replimune Group, Inc. $REPL - MarketBeat
Trexquant Investment LP Sells 42,056 Shares of Replimune Group, Inc. $REPL - MarketBeat
Analysts Set Replimune Group, Inc. (NASDAQ:REPL) Price Target at $6.50 - Defense World
REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm - PR Newswire
Replimune Group, Inc. Class Action: The Gross Law Firm - GlobeNewswire
Replimune Group, Inc. INVESTOR ALERT: Kirby McInerney LLP Notifies Replimune Group, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL - GlobeNewswire Inc.
Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025REPL - Newsfile
Replimune Group's (REPL) "Neutral" Rating Reaffirmed at HC Wainwright - MarketBeat
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Louisiana First News
Replimune Group, Inc. (NASDAQ: REPL) Investor Alert: Deadline in Lawsuit on September 22, 2025 - openPR.com
Replimune Group, Inc. Investors: Please contact the Portnoy - GlobeNewswire
Replimune Group, Inc. (REPL) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 22, 2025 Deadline - ACCESS Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Business Wire
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025REPL - Morningstar
Replimune Group’s (REPL) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World
Shareholders of Replimune Group, Inc. (REPL): Protect Your Rights Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
Shareholders SueWallSt in New Class Action Against Replimune Group, Inc.Act Now - Nasdaq
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming DeadlinesREPL - PR Newswire
REPLIMUNE GROUP, INC. (NASDAQ: REPL) SHAREHOLDER ALERT - GlobeNewswire
The Gross Law Firm Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025REPL - Morningstar
Replimune Group, Inc. $REPL Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
Lost Money on Replimune Group, Inc. (REPL)? Contact Levi & Korsinsky Before September 22, 2025 to Join Class Action - ACCESS Newswire
Faruqi & Faruqi Reminds Replimune Investors of the Pending - GlobeNewswire
REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
Real time alert setup for Replimune Group Inc. performanceJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Securities Fraud Class Action Filed Against Replimune Group, Inc. (REPL)Levi & Korsinsky Reminds Investors of September 22, 2025 - ACCESS Newswire
Assessing Legal and Market Risks in Replimune Group, Inc. (REPL) Amid Ongoing Class Action Lawsuits - AInvest
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - The Malaysian Reserve
Replimune Group, Inc. (REPL) Investors: September 22, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm - PR Newswire
How to contact the Daily Bulletin - FinancialContent
Can Replimune Group Inc. continue delivering strong returns2025 Year in Review & Daily Technical Stock Forecast Reports - خودرو بانک
Will Replimune Group Inc. continue its uptrend2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser
Securities Fraud and Shareholder Risk at Replimune Group (REPL): Assessing the Financial and Reputational Impact of Securities Litigation on Biotech Valuations - AInvest
Full technical analysis of Replimune Group Inc. stockJuly 2025 Review & Low Risk High Win Rate Stock Picks - Newser
Investor Alert: Deadline Approaching to Join Replimune Group, Inc. (REPL) Class Action – Contact Levi & Korsinsky - ACCESS Newswire
Replimune Group Schedules Crucial FDA Meeting for RP1 - TipRanks
The Gross Law Firm Announces the Filing of a Securities - GlobeNewswire
Replimune Group, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights - FinancialContent
Silicon Valley - FinancialContent
Replimune Group Inc (REPL) 財務データ
収益
当期純利益
現金流量
EPS
Replimune Group Inc (REPL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Astley-Sparke Philip | Director |
May 20 '25 |
Sale |
8.06 |
32,279 |
260,169 |
1,405,071 |
| Xynos Konstantinos | Chief Medical Officer |
May 20 '25 |
Sale |
8.06 |
7,952 |
64,093 |
146,933 |
| Schwendenman Andrew | Chief Accounting Officer |
May 20 '25 |
Sale |
8.05 |
3,287 |
26,460 |
68,284 |
| Patel Sushil | Chief Executive Officer |
May 20 '25 |
Sale |
8.06 |
25,105 |
202,346 |
343,576 |
| Hill Emily Luisa | Chief Financial Officer |
May 20 '25 |
Sale |
8.05 |
2,535 |
20,407 |
143,522 |
| Sarchi Christopher | Chief Commercial Officer |
May 20 '25 |
Sale |
8.05 |
3,749 |
30,179 |
128,296 |
| Patel Sushil | Chief Executive Officer |
Dec 16 '24 |
Sale |
12.42 |
10,000 |
124,200 |
202,014 |
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):